BackAcelyrin Overview

Acelyrin Total Current Liabilities

Latest total current liabilities for SLRN: $23M.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$23.30M
55.43% YoYΔ $-28.98M vs prior year quarter

Peer average

Loading

Acelyrin Total Current Liabilities History

Loading

Acelyrin vs. peers: Total Current Liabilities Comparison

Loading

Acelyrin Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Acelyrin (SLRN) FAQ

Acelyrin (SLRN) currently reports a total current liabilities of $23M as of March 2025. That compares with $52M in the prior-year period — down 55.4% year over year. Use the charts on this page to explore Acelyrin's total current liabilities history and peer comparisons.

Acelyrin's total current liabilities decreased from $52M to $23M — a 55.4% year-over-year decrease (period ending March 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Acelyrin reported $23M in total current liabilities as of March 2025. That compares with $52M in the prior-year period — down 55.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $23M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Acelyrin, and consider following SLRN for alerts when major investors trade the stock.